Chicago’s life sciences industry could in 2024 be one of the few bright spots in the city’s struggling office market. A flurry of new leases signed by expanding research firms, along with record-setting amounts of federal grants flowing to local biotech startups, has developers anticipating strong growth in the sector, enough to kick-start new towers dedicated to life sciences. “Chicago to me is a really vibrant, fresh place,” said Frank Cassou, CEO at CycloPure Inc., which just agreed to relocate its headquarters from the suburbs to 2430 N. Halsted St. in Lincoln Park, the former Stanley Manne Children’s Research Institute…
